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Abstract  
Malaria is majorly caused by Plasmodium falciparum resulting in thousands of deaths every year. In Africa, it is 
a key contributor to the disease burden notable in the disability adjusted life years (DALYs). About 243 million 
individuals are at a risk of contracting the disease and a higher rate of deaths are observed in children under the 
age of five. Conventional drugs are available at a subsidized rate but the rising problem is the resistance of the 
plasmodium parasite to these drugs. Hence, there is an urgent need for the development of new and alternative 
therapeutics for treatment of malaria. In some regions in Kenya, parts of locally available plants are harvested 
and used for treating malaria. It is estimated that locally, 30% of the population relies on traditional medicine for 
treating various ailments due to the lack of infrastructure and accessible medical facilities especially in the rural 
areas. Warbugia ugandensis, Maytenus senegalensis and Corymbia citriodora are amongst the plants used in 
herbal medicine for the treatment of malaria. However, their combinatorial antimalarial efficacy and safety is yet 
to be determined hence the aim of this study. The plants were harvested from their natural habitats and 
transported to the Centre of Traditional Medicine and Drug Research (CTMDR) at the Kenya Medical Research 
Institute (KEMRI), Nairobi. Antimalarial properties of single and combined extracts were analyzed against 
Plasmodium berghei in vivo. Cytotoxic properties of the plants were carried out against the vero cell-lines in 
vitro by the MTT assay. Acute oral toxicity was conducted according to the OECD protocol. Effective 
concentration (ED50), cytotoxicity concentration (CC50) and median lethal dose (LD50) were derived. The result 
indicated that the combination of M. senegalensis: W. ugandensis (1:1) had the most antimalarial activity at ED50 
of 1.05mg/kg whereas among the single plants W. ugandensis had the highest antimalarial activity (ED50 of 
3.3mg/kg). The combinations of C. citriodora: M. senegalensis: W. ugandensis (1:1:1), C. citriodora: M. 
senegalensis: W. ugandensis (1:0.5:1) and C. citriodora: M. senegalensis: W. ugandensis (0.5:1:0.5) showed 
cytotoxicity concentration (CC50) of 101.47±3.17 µg/ml, 213.55±3.47 µg/ml and 575.80±31.40 µg/ml 
respectively. All the plants combinations showed no cytotoxic effects. The synergistic antimalarial properties of 
combined C. citriodora: M. senegalensis, C. citriodora: W. ugandensis and M. senegalensis: W. ugandensis were 
confirmed as the extracts showed SFIC indexes of 0.67, 0.83 and 0.28 respectively. All the plant extracts 
demonstrated LD50 above 2000 mg/kg with no adverse effects hence recognized as safe. This study confirms the 
safety and antimalarial activities of these plants and justify their use in herbal medicine practices. The results of 
this study sets the precedence for the development of an antimalarial herbal formulation that is less toxic and 
more affordable.  
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Introduction 
Malaria is a mosquito-borne parasitic disease caused by Plasmodium species (Miller et al., 2013; Ghani, 2018). 
Mammalian hosts are the exclusive targets for Plasmodium falciparum and Plasmodium vivax with the former 
causing the most malaria burden globally (Global Health, 2008; Tangpukdee et al., 2009; Clemente and 
Corigliano, 2012). Various strategies have been enlisted for the treatment, management and eradication of the 
disease such as vector control, chemosuppression and vaccines. Despite all the established efforts to eradicate 
malaria, the disease still causes significant morbidity and mortality especially in developing countries. 
Inaccessibility and unaffordability of conventional healthcare for treatment of malaria has motivated 
communities to use herbal medicine for the management of malaria. Approximately, 75% of the African 
population uses traditional medicine for treating human ailments (Clarkson et al., 2004; Ogollah, 2015). It has 
been suggested that the development of direct herbal formulations will provide dosage descriptions leading to 
cheaper and more affordable sources of drugs to the communities in which they belong. Due to natural origin 
and prolonged traditional use of herbal medicines they are considered safe (Willcox and Bodeker, 2004). 
Primarily, mortality and morbidity rates caused by malaria have reduced because of local herbal therapeutics 
particularly in parts of developing countries where conventional antimalarial drugs are not readily accessible, 
affordable and available (Kigondu et al., 2011). Despite their continued use, herbal treatments have a number of 
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deficits such as lack of precise diagnosis from laboratory results, plant extracts identification may be obscure, 
their chemical constituents are unknown and their efficacy yet validated scientifically (Ancolio, et al., 2002). 
World Health Organization recommends that plant efficacy and safety should be scientifically validated. More 
importantly based on the scientific background the plants can serve as novel drugs or templates for development 
of new therapeutic drugs. Hence, the basis of this study. 
 
2.0 Materials and Methods 
2.1 Materials 
2.1.1 Plant materials 
The Plant materials; Warbugia ugandensis stem bark from Kinangop, Maytenus senegalensis stem bark from 
Kinangop and Corymbia citriodora leaves from Tharaka Nithi, 5kg each were collected in gunny bags from their 
natural habitat in Kenya. Authentication was done at the East African herbarium, National Museum of Kenya 
and voucher specimen subsequently deposited at the herbarium. A taxonomist was involved during the collection 
and authentication process. The plant parts were then delivered to CTMDR, KEMRI.  
Botanical Name                                  Family                   Voucher Number             Parts used 
Corymbia citriodora                             Myrtle                           PK03                         Leaves 
Warbugia Ugandensis                          Magnoliidae                TFm11                      Stem bark 
Maytenus senegalensis                        Celestaceae                 Fm10                      Stem bark 
2.1.2 Animals 
Swiss mice (18- 25g) were obtained from the animal facility at Kenya Medical Research Institute, Nairobi. The 
mice were nulliparous and acclimatized to experimental room for a fortnight. The animals were supplied with 
water ad libitum and food as per experimental procedures. The mice were placed in standard conditions of 
humidity (40-65%), temperature and 12-hour light/ darkness cycle. 
2.1.3 Innoculum 
The chloroquine sensitive Plasmodium berghei (ANKA) was obtained from Kenya Medical Research Institute 
Nairobi. A Swiss mouse containing P. berghei at a parasitaemia level of 20-30% was used as the donor 
inoculum. Parasitized erythrocytes were harvested from the donor mouse using a sterile needle and syringe 
coated with heparin. The blood was then diluted with phosphate saline glucose(PSG) buffer to obtain 1 ml blood 
containing 1×107 parasitized erythrocytes.  
 
2.2 Methods 
2.2.1 Plant material 
Clean plant parts were air- dried at room temperature (25o C) for a fortnight. Once completely dried, the plant 
parts were ground using an electric mill into powder form then separately stored in sealed containers at room 
temperature. A portion (100g) of each of the powdered plant part was put in 1 litre of distilled water and heated 
in a water bath at 70°C for 90 minutes. The extract was decanted into a clean dry 3 litre conical flask followed 
by filtering through a cotton gauze. The filtered extract was then lyophilized using an Edwards freeze dryer 
Modulyo into powder form and then pooled into an air tight bottle, weighed, labeled and stored at 40 C awaiting 
use. 
2.2.2 Cell cultures 
Vero E6 cell line cells obtained from the American Type Culture Collection were cultured in Minimum Essential 
Media supplemented with L-Glutamine, 10% heat inactivated fetal bovine serum (FBS), 1% of penicillin and 
streptomycin then maintained at 37˚C in a humidified atmosphere of 5% CO2. 
2.2.2.1 MTT assay 
An amount of 50 mg each of the different extract ratios was dissolved in 5ml double distilled water to give stock 
solutions of 10mg/ml each. This stock solution was then dissolved in 0.5 ml DMSO Dimethyl Sulfoxide 
(DMSO). Double distilled water was then added to give a stock solution of 10mg/ml ensuring that the final 
concentration of DMSO is 1% as it is toxic beyond this percentage. This one-part stock solution was diluted to 
99 parts of Earl’s Minimum Essential Medium (MEM) (ratio of 1:99), containing 2% Fetal Bovine Serum (FBS, 
maintenance medium), which was 10µl of the extract in 990 µl of media giving a start concentration of 1000 µg/ 
ml in 1% DMSO used in the MTT ((3- [4, 5- dimethylthiazol -2- yl) -2,5- diphenyltetrazolium bromide) assay.  
In vitro cytotoxicity assay was carried out following a modified rapid calorimetric assay Mosmann (1983). 
Vero E6 cell line, 1ml, containing 1500-2000 cells was retrieved from liquid nitrogen storage and viability of the 
cells determined using Trypan blue exclusion assay. The cells were revived and cultured in T-75 flasks with 
Earl’s Minimum Essential Media (EMEM), supplemented with penicillin & streptomycin (1%) and 10% Fetal 
Bovine Serum maintained at 37˚C in a humidified atmosphere of 5% CO2 to achieve a monolayer.  
Cell monolayer was broken into single cells using trypsin after achieving 70-100% confluence. Cell density 
count of viable cells was determined. A 96- well micro titer plate was used. A cell suspension (10 µl) containing 
2 x 105 viable cells was then seeded onto columns 1,2,4,5,7,8,10,11 whereas 10 µl of media without vero cells 
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was added onto rows 3,6,9 and 12. The plate was then incubated at 37oC in 5 % CO2 for 24 hours to allow the 
cells to attach. After which the different combination of the drugs was serially added to the cells from rows H to 
row B.  
Treatment protocol for cytotoxicity assay 
Treatment Groups  Concentration (µl/ml) 
Negative Control (Distilled water) 150  
Positive Control                        15 
Extract Treatments  
i.  1.37 
ii.  4.12 
iii.  12.35 
iv.  37.04 
v.  111.11 
vi.  333.33 
vii.  1000 
Different combination ratios of the combined drug extracts of C.citriodora, M.senegalensis and 
W.ugandensis was serially added to the wells. The plates were then incubated for 48 hours at 37oC in 5 % CO2. 
Upon incubation, 10 µL of MTT dye was added to all the cells in the plates. The plates were incubated for 
another 4 hours then entire media plus MTT dye was aspirated off followed by addition of 100 µl of DMSO and 
shaken for 5 minutes to dissolve the formazin.  
The plates were read on a scanning multi well spectrophotometer (Multiskan Ex Labssystems) at 562 nm 
and 690 nm as reference to determine the extent of cell viability. 
2.2.1 Four day chemosuppressive antimalarial activity test 
The blood was obtained from the second passage and collected in containers coated with heparin. The blood was 
diluted with phosphate saline glucose buffer(PSG) to obtain 1 ml blood containing 1×107 parasitized 
erythrocytes. A volume of 0.2ml per mouse containing 1x 107 parasitized erythrocytes was intraperitoneally 
injected into 25 mice using a 27-gauge needle. The animals were then randomly divided into six groups each 
comprising of five animals. After 2 hours, a randomized group of animals was orally treated with the vehicle; 
distilled water), reference drug (Chloroquine) and plant extracts as shown in table 3.2 using a 26-gauge stainless 
steel cannula. The group treated with the vehicle served as the negative control while chloroquine treated group 
was the positive control. On the 4th day, the mice were pricked at the tail tip and drops of blood collected on a 
microscope slide. The collected blood was used to prepare thin smears which were stained with giemsa dye then 
viewed under a microscope to observe and count the number of infected red blood cells. Parasitemia was 
determined microscopically by counting four fields on the microscope slide having approximately 100 
erythrocytes per field. The number of infected erythrocytes against the number of total erythrocytes in the field 
was recorded.  
%Parasitemia= Number of Parasitized RBCs x100 
  Total number of RBCs 
Chemosuppression= Parasitemia in Negative Control- Parasitemia in treatment group x100 
    Parasitemia in Negative Control 
2.2.4 In vivo acute toxicity 
The acute oral toxicity test was closely monitored in intervals of 0, 15, 30, 45min, 1hour,6hr,12hr,24hr, 36hr, 
48hr according to OECD 425 protocol (OECD, 2005). Fifteen nulliparous and non-pregnant female (8-12 weeks 
old, 18 - 25g) Swiss mice were acclimatized to laboratory conditions for five days prior to dosing. Five groups 
(comprised of three mice) were randomly picked and placed in a marked cage. The mice were fasted for 3 hours 
prior dosing and their weight determined. A single dose of 0.2 ml (1ml/ 100g of mouse weight) containing 
combined plant extract at 5, 50, 300, 2000 mg/kg body weight doses was orally administered per group of mice 
using a 20 gauge oral gavage stainless steel cannula. Food was withheld for 2 hours after treatment with the plant 
extract.  
A single group of mice (3 mice) were first administered with 5mg/kg initial dose and monitored for 48 
hours. If none or one mouse dies, then a higher dose would be administered to another group of three mice. The 
first 48 hours for observation is crucial to ensure survival of the group of mice before proceeding to a higher 
dose. Toxicity was monitored and the vehicle/ negative control (distilled water) was given to the normal group. 
Signs of toxicity such as changes in breathing patterns, weight loss, reduced activeness and eventual death were 
checked within the first 48 hours after treatment. At the end of 14 days, weight of the surviving animals was 
recorded and humanely sacrificed. 
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3.0 RESULTS AND DISCUSSION 
3.1 Plant extract species and yield 
Plant species Part Weight before yield (g) Weight after yield 
Corymbia citriodora Leaf 100 11.2 
Maytenus senegalensis Stem bark 93 17.5 
Warbugia ugandensis Roots 100 23.91 
The percentage yield of the plant extract Corymbia citriodora was slightly higher than the ethanolic E. citriodora  
extract of 9.32% by Muhammed et al (D.Muhammed, 2018).  
 
3.2 In vitro cytotoxicity of C. citriodora, M. senegalensis and W. ugandensis 
In vitro safety profile of the plant extract was established by determined the concentration that reduced vero cells 
by 50% (CC50). Chloroquine had the highest cytotoxic effect with a CC50 value of 71.13±1.63 µg/ml. C. 
citriodora: M. senegalensis: W. ugandensis (1:1:1) and C. citriodora: M. senegalensis: W. ugandensis (1:0.5:1) 
had CC50 value of 101.47±3.17 µg/ml and 213.55±3.47 µg/ml respectively with no observed cytotoxicity to the 
vero cells. The least CC50 was shown by C. citriodora: M. senegalensis: W. ugandensis (0.5:1:0.5) at of 
575.80±31.40 µg/ml. The cytotoxicity exhibited by chloroquine was statistically higher from the cytotoxicity 
shown by all the plant extracts. 
Table 3.2.1 Cytotoxic effects of various extract combination on vero cells 
Treatments CC50 Values (µg/ml) 
Chloroquine 71.13±1.63 
C. citriodora: M. senegalensis: W. ugandensis (1:1:1) 101.47±3.17 
C. citriodora: M. senegalensis: W. ugandensis (1:0.5:1)   213.55±3.47 
C. citriodora: M. senegalensis: W. ugandensis (0.5:1:0.5)  575.80±31.40 
All values are expressed as Mean±SEM  
The MTT ([3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyl tetrazolium bromide]) assay is used to test for cell 
viability in which living cells reduce tetrazolium salt in a reaction catalyzed by the mitochondrial dehydrogenase 
enzyme (Freimoser et al., 1999; Ogollah, 2015). Vero cells are recommended for cytotoxicity assays of plant 
extracts and nutraceuticals in biomaterial research since they mimic normal body cells (Kirkpatrick, 1992; ISO, 
1997). The cell line was subjected to extracts treatment upon which the CC50 values were determined. 
Accordingly, C. citriodora: M. senegalensis: W. ugandensis (1:1:1), C. citriodora: M. senegalensis: W. 
ugandensis (1:0.5:1) C. citriodora: M. senegalensis: W. ugandensis (0.5:1:0.5) showed no cytotoxic effects with 
CC50 values of 101.47±3.17 μg/ml, 213.55±3.47 μg/ml and 575.80±31.40 μg/ml respectively. 
Previous findings corroborate the safety properties of the aqueous extract of the plant extracts as observed 
in the current study. Nabende (2015) corroborated the findings of this study where it was observed that the 
aqueous leaf extracts of M. senegalensis had no cytotoxic effects against the vero cell lines (CC50 values 
>1000µg/ml). This study also confirms the findings of Nobakht et al. (2017) that C. citriodora, C. torelliana C. 
citriodora and C. torelliana showed no cytotoxicity activity Vero cells tested using 1000 µg/ml.  
 
3.3 Four day chemosuppressive antimalarial activity test 
Combinations of two plants extracts were tested for antimalarial activity. The combinations tested included C. 
citriodora: M. senegalensis (C: M), C. citriodora: W. ugandensis (C: W) and M. senegalensis: W. ugandensis 
(M: W) at the ratio of 1:1. The percentage chemosuppression of P. berghei growth by all the extracts was 
statistically lower than the positive control chloroquine but statistically higher than the negative control.  
It was observed that the combinations of C. citriodora: M. senegalensis (C: M) and M. senegalensis: W. 
ugandensis (M: W) had dose related antimalarial activity. Correspondingly, as the concentration of the extracts 
increased, the percentage chemosuppression of P. berghei proliferation reduced (table 3.3.1). On the other hand, 
C. citriodora: W. ugandensis (C: W) showed highest chemosuppression (88.80±0.44%) at lowest concentration 
of 75mg/kg (table 3.3.1). Comparison of the three extracts indicated that M. senegalensis: W. ugandensis (M: W) 
had the highest chemosuppression activity of 95.35% in comparison to Chloroquine. The combination of C. 
citriodora: M. senegalensis (C: M) had the lowest chemosuppression activity of 76.72% in comparison to all the 
other extracts used in this study.  
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Further, the three plants (C. citriodora: W. ugandensis: M. senegalensis) were combined in the ratio of 
1:1:1 and their antimalarial activities determined (table 3.3.2). An inverse dose dependent trend of inhibition was 
observed. Consequently, the highest percentage chemosuppression (77.06±0.41%) was observed at the lowest 
concentration (75mg/kg) of the plant extracts. The results also indicated that the combination of the three plants 
was statistically higher than the negative control group although statistically lower than the standard drug 
chloroquine. The three plant combination extract showed lower chemosuppression values than the two plant 
extract combinations. This highlights the need to sensitize the community on the importance of extract 




3.5 Acute Toxicity 
Acute toxicity of the plant extracts was carried out on Swiss mice and body weights determined. Generally, there 
was an increment of the animals’ body weight after the extract administration hence extract administration did 
not affect weight gain. Mortality did not occur from onset of drug administration until the 14- day observation 
period. No animals died at the highest concentration of the treatment hence the lethal dose (LD50) was inferred to 
be above 2000mg/kg/ oral hence considered safe and nontoxic (Bello et al., 2005). The mice behavioral 
indicators such as reduced activity, diarrhea, paw licking, convolution and hyperactivity were not observed in 
this study. 
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Table 3.5.1 Effects of C. citriodora: M. senegalensis: W. ugandensis (1:1:1) on mice body weight  
Concentrations Weight before extract 
administration (g) 
















300mg/kg 19.60±0.51a 26.40±0.81a 24.98±3.35a 
2000mg/kg 19.40±0.51a 26.00±0.32a 24.54±2.46a 
Chloroquine 19.00±0.32a 26.00±1.00a 26.50±2.05a 
LD50                              >2000mg/kg 





The significant findings from this study supports the antimalarial ethnomedicinal claimed combination of 
C.citriodora, M.senegalensis and W.ugandensis in treating malaria. Attention to the extract combination ratios is 
crucial for the effective treatment of malaria. The results show a possibility of developing new anti-malarial 
novel compound using thorough molecular mechanism and characterization studies. 
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